Aranthan Jones II, Chief Corporate Affairs Officer at Vanda Pharmaceuticals Inc. (VNDA), sold 7,730 shares at $18.04 ($139K) on 2021-03-02, disclosed to the SEC on 2021-03-03.
Open-market sale of $139k VNDA by Chief Corporate Affairs Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $18.04 | 3,865 | $70K | 50.0% |
| 2 | $18.04 | 3,865 | $70K | 50.0% |
| Total | $18.04 avg | 7,730 | $139K | 100% |
| Filing → |
| VNDA | SELL | 2021-03-16 | $319K | — | Filing → |
| VNDA | SELL | 2021-02-26 | $920K | — | Filing → |
| VNDA | SELL | 2020-08-14 | $85K | — | Filing → |